TELA Bio
TELA
29 hedge funds and large institutions have $50.6M invested in TELA Bio in 2020 Q1 according to their latest regulatory filings, with 11 funds opening new positions, 7 increasing their positions, 6 reducing their positions, and 4 closing their positions.
175% more first-time investments, than exits
New positions opened: 11 | Existing positions closed: 4
32% more funds holding
Funds holding: 22 → 29 (+7)
17% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 6
0.97% more ownership
Funds ownership: 55.95% → 56.93% (+0.97%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
39% less capital invested
Capital invested by funds: $82.7M → $50.6M (-$32M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAC
Cowen and Company
New York
|
+$5.16M |
| 2 |
EWM
Essex Woodlands Management
The Woodlands,
Texas
|
+$4.12M |
| 3 |
SMH
Sanders Morris Harris
Houston,
Texas
|
+$249K |
| 4 |
Citadel Advisors
Miami,
Florida
|
+$189K |
| 5 |
DTL
Dynamic Technology Lab
Singapore
|
+$182K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Federated Hermes
Pittsburgh,
Pennsylvania
|
-$3.15M |
| 2 |
WP
Woodline Partners
San Francisco,
California
|
-$2.54M |
| 3 |
OM
Opaleye Management
Boston,
Massachusetts
|
-$1.27M |
| 4 |
SSA
Schonfeld Strategic Advisors
New York
|
-$1.04M |
| 5 |
Wellington Management Group
Boston,
Massachusetts
|
-$355K |
TELA Hedge Fund Activity: Q1 2020 in Review
29 of the 4,547 institutional investors tracked by Wall St. Rank reported a position in TELA Bio (TELA) for Q1 2020, worth a combined $50.6M — down 39% from $82.7M a quarter earlier.
Buyers outnumbered sellers: 11 funds opened new TELA positions and 4 closed out — a net gain of 7 holders — while 7 added to existing stakes and 6 trimmed.
The largest buyer was Cowen and Company, adding an estimated $5.16M. The largest seller was Federated Hermes, cutting an estimated $3.15M.
- 29 institutional investors held TELA Bio (TELA) as of Q1 2020, up from 22 in Q4 2019.
- Funds reported $50.6M of TELA Bio stock for Q1 2020, down 39% quarter-over-quarter.
- 11 funds opened new TELA Bio positions in Q1 2020 and 4 closed out, a net change of +7 holders.
- The largest TELA Bio buyer in Q1 2020 was Cowen and Company, an estimated $5.16M added.
- The largest TELA Bio seller in Q1 2020 was Federated Hermes, an estimated $3.15M sold.
Based on aggregated 13F filings for Q1 2020.